Journal Article10.1007/S00018-004-4020-4
Lipopolysaccharide-binding molecules: transporters, blockers and sensors
79
TL;DR: A better understanding of the mode of recognition of LPS by cognate proteins prompted many laboratories to design on a rational basis synthetic molecules which can be used to detect low amounts of endotoxin, or to act as efficient blockers of in vitro and in vivo responses to LPS.
read more
Abstract: Lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria, can be beneficial to the host by activating the innate immune system, or harmful, by inducing inflammation, disseminated intravascular coagulation, multiple organ failure, shock and often death. On the bacteria, and in host biological fluids and cells, LPS is never free but constantly attached to cognate-binding proteins. Understanding how LPS is transported and further recognized by sensors able to deliver a signal, or by inactivating molecules able to neutralize its biological effects, is an important goal. This review describes the large panel of peptides and proteins reported to associate with LPS, and provides information on their origin, their structure and the location of amino acid residues involved in their interaction with LPS. A better understanding of the mode of recognition of LPS by cognate proteins prompted many laboratories to design on a rational basis synthetic molecules which can be used to detect low amounts of endotoxin, or to act as efficient blockers of in vitro and in vivo responses to LPS.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Recent Advances in Lipopolysaccharide Recognition Systems.
Lalita Mazgaeen,Prajwal Gurung +1 more
TL;DR: A brief history of LPS discovery is detailed, followed by the discovery of TLR4, TRP as the membrane-bound sensor, and the current understanding of caspase-4/5/11 as cytoplasmic sensors.
276
Recombinant expression and anti-microbial activity of anti-lipopolysaccharide factor (ALF) from the black tiger shrimp Penaeus monodon
Kunlaya Somboonwiwat,Michael Marcos,Anchalee Tassanakajon,Sirawut Klinbunga,André Aumelas,Bernard Romestand,Yannick Gueguen,Hélène Boze,Guy Moulin,Evelyne Bachère +9 more
TL;DR: Anti-microbial assays demonstrated that rALFPm3 has a broad spectrum of anti-fungal properties against filamentous fungi, and anti-bacterial activities against both Gram-positive and Gram-negative bacteria, associated with a bactericidal effect.
215
Gut microbiota and immune crosstalk in metabolic disease
TL;DR: Recent evidence in rodents allows us to conclude that an impaired intestinal immune system characterizes and could be causal in the development of metabolic disease.
176
Growth and Development Symposium: Endotoxin, inflammation, and intestinal function in livestock.
TL;DR: The evidence that intestinal transport of endotoxin and the subsequent inflammation leads to decrease in the production performance of agricultural animals is summarized and an overview of endot toxin detoxification mechanisms in livestock is presented.
170
Sepsis: mechanisms of bacterial injury to the patient
TL;DR: A bacterium killing is only one of numerous aspects of antibacterial therapy that should inhibit the production of bacterial antioxidant enzymes and hemolysins, neutralize bacterial toxins, modulate bacterial respiration, increase host tolerance to bacterial products, facilitate host bactericidal mechanism and disperse bacterial capsule and biofilm.
References
Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.
TL;DR: It is anticipated that the protecting effect of endogenous chylomicrons against LPS-induced endotoxemia may result from the apoE moiety and that human recombinant apOE may serve as a therapeutic means to protect against endotoxemic disease.
Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
TL;DR: The broad-spectrum antimicrobial properties of LL-37, its presence in neutrophils, and its inducibility in keratinocytes all suggest that this peptide and its precursor (hCAP-18) may protect skin and other tissues from bacterial intrusions and LPS-induced toxicity.
Lipopolysaccharide (LPS) Neutralizing Peptides Reveal a Lipid A Binding Site of LPS Binding Protein
Alexander H. Taylor,George A. Heavner,Mark Nedelman,David Sherris,Eva Brunt,David C. Knight,John Ghrayeb +6 more
TL;DR: Results suggest Lipopolysaccharide binding protein residues 91-108 form at least part of the lipopolysacCharide binding site, and derivatives of lipopoly Saccharidebinding protein residues91-108 might modulate lipopolySaccharide toxicity in the clinical setting.
•Journal Article
Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.
TL;DR: Examination of TNF release in rabbit peritoneal exudate macrophages shows LBP-treated M phi showed a more rapid induction of cytokine mRNA (TNF and IL-1 beta), higher steady-state mRNA levels and increased TNF mRNA stability, providing additional evidence that LBP is part of a highly specific recognition system controlling Mphi responses to LPS.
Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide
Elisabeth Elass-Rochard,Anca Roseanu,Dominique Legrand,Mihaela Trif,Valérie Salmon,C Motas,Jean Montreuil,Geneviève Spik +7 more
TL;DR: The report reveals the presence of two Escherichia coli 055B5 LPS-binding sites on human Lf (hLf): a high-affinity binding site (Kd 3.6 +/- 1 nM) and a low-affination binding site(Kd 390 +/- 20 nM).